Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations

v3.25.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
Grant revenue $ 37,653
Operating expenses:    
Research and development 4,114,434 15,490,604
General and administrative 6,444,381 5,451,952
Total operating expenses 10,558,815 20,942,556
Loss from operations (10,558,815) (20,904,903)
Other income (expense):    
Interest income 45,897 210,394
Interest expense (29,828) (30,591)
Miscellaneous income 69,363
Foreign currency exchange, net (25,172)
Total other income (expense), net (9,103) 249,166
Loss before income taxes (10,567,918) (20,655,737)
Income tax benefit
Net loss $ (10,567,918) $ (20,655,737)
Basic net loss per share $ (1.60) $ (9.18)
Diluted net loss per share $ (1.60) $ (9.18)
Shares used to compute basic net loss per share 6,621,934 2,249,694
Shares used to compute diluted net loss per share 6,621,934 2,249,694